Skip to main content

Nexus Pharmaceuticals Plans Manufacturing Complex

Published 7/22/2019

Nexus Pharmaceuticals will begin construction in August of 2019 on a $250 million manufacturing complex in Pleasant Prairie, Wis. The multi-phase project will be delivered over the next ten years, enabling Nexus to expand its production capacity for sterile injectable drugs. The first phase comprises an $85 million manufacturing building featuring an advanced isolator system and multiple lyophilization machines. The three-story, 84,450-sf structure was designed by Integrated Project Services and will be built by Turner Construction. Completion is expected by 2021 with commercial production commencing in 2022.

Organization Project Role
Integrated Project Services
Architect and Engineer
Turner Construction
Construction Manager